Kairos Pharma Ltd. (KAPA)
1.73
-0.08
(-4.42%)
USD |
NYAM |
Sep 18, 16:00
1.75
+0.02
(+1.16%)
After-Hours: 20:00
Kairos Pharma EPS Diluted (Quarterly) : -0.4536 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.4536 |
| March 31, 2026 | -0.551 |
| December 31, 2025 | -0.4589 |
| September 30, 2025 | -0.4843 |
| June 30, 2025 | -0.5783 |
| March 31, 2025 | -0.5564 |
| December 31, 2024 | -0.4994 |
| September 30, 2024 | -0.5705 |
| June 30, 2024 | -0.1378 |
| Date | Value |
|---|---|
| March 31, 2024 | -0.176 |
| December 31, 2023 | -0.6092 |
| September 30, 2023 | -0.17 |
| June 30, 2023 | -0.1286 |
| March 31, 2023 | -0.0795 |
| December 31, 2022 | -0.1068 |
| September 30, 2022 | -0.1275 |
| June 30, 2022 | -0.2098 |
| March 31, 2022 | -0.128 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.388M |
| Total Expenses (Quarterly) | 1.388M |
| Enterprise Value | 2.669M |
| Earnings Yield | -112.6% |
| Normalized Earnings Yield | -108.72 |